Invention Grant
US07674597B2 Signaling intermediates in an in vitro model of Alzheimer's disease
失效
信号中间体在阿尔茨海默病的体外模型
- Patent Title: Signaling intermediates in an in vitro model of Alzheimer's disease
- Patent Title (中): 信号中间体在阿尔茨海默病的体外模型
-
Application No.: US11193353Application Date: 2005-08-01
-
Publication No.: US07674597B2Publication Date: 2010-03-09
- Inventor: Nikolay Malinin , Maile Skomp , Sarah Wright , Irene Griswold-Prenner
- Applicant: Nikolay Malinin , Maile Skomp , Sarah Wright , Irene Griswold-Prenner
- Applicant Address: US CA South San Francisco
- Assignee: Elan Pharmaceuticals, Inc.
- Current Assignee: Elan Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Townsend and Townsend and Crew LLP
- Main IPC: G01N33/567
- IPC: G01N33/567 ; G01N33/53
Abstract:
The invention provides a novel human protein, FISH adaptor protein, involved in amyloid β-protein-mediated cell death. Also provided are methods for modulating amyloid β-protein-mediated cell death using agents that interfere with the activity of FISH adaptor protein.
Public/Granted literature
- US20060159674A1 Signaling intermediates in an in vitro model of Alzheimer's disease Public/Granted day:2006-07-20
Information query
IPC分类:
